Literature DB >> 11479866

The management of prenatally diagnosed choledochal cysts.

T C Mackenzie1, L J Howell, A W Flake, N S Adzick.   

Abstract

BACKGROUND: Although congenital biliary tree abnormalities are uncommon in the United States, more are being diagnosed antenatally with improved imaging techniques.
METHODS: To determine the prognosis of prenatally diagnosed biliary disease, the authors reviewed the treatment of 3 children who had biliary cystic lesions found during routine prenatal ultrasonography.
RESULTS: All 3 children were born at term. They had elevated bilirubin levels, and postnatal ultrasound scans confirmed the presence of a biliary cystic mass. They underwent exploration within 2 weeks of life. At operation, 2 children were found to have biliary atresia with a cystic biliary lesion. They underwent Kasai procedures and are doing well at 5 and 9 months of age. The third child was found to have a type I choledochal cyst and malrotation at exploration. He underwent cystectomy with Roux-en-Y hepaticojejunostomy and a Ladd's procedure and is doing well at 3 years of age.
CONCLUSIONS: Prenatally diagnosed biliary cysts represent a different spectrum of disease than those diagnosed later in life. The sequelae of biliary disease start before birth, and early operation may be necessary to achieve a good outcome. Because it is impossible to distinguish between choledochal cysts and biliary atresia on antenatal ultrasound scan or magnetic resonance imaging, children with presumed choledochal cysts should undergo early exploration to rule out potential biliary atresia. Excellent outcome is possible with early operation in the absence of severe associated anomalies. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2001        PMID: 11479866     DOI: 10.1053/jpsu.2001.25784

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Disappearing cyst of the hepatic hilum in uncorrectable biliary atresia.

Authors:  Jun Fujishiro; Tadashi Iwanaka; Mari Arai; Hiroshi Kawashima; Sumi Kudou; Satohiko Imaizumi; Sumiko Hirukawa; Orie Inasaka
Journal:  Pediatr Surg Int       Date:  2005-01-06       Impact factor: 1.827

2.  Prenatal diagnosis of choledochal cyst using magnetic resonance imaging: a case report.

Authors:  Alex Mun-Ching Wong; Yun-Chung Cheung; Yu-Hung Liu; Koon-Kwan Ng; Siu-Cheung Chan; Shu-Hang Ng
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

Review 3.  Chemoprevention of Colorectal Cancer.

Authors:  Bryson W Katona; Jennifer M Weiss
Journal:  Gastroenterology       Date:  2019-09-26       Impact factor: 22.682

4.  Laparoscopic management of antenatally detected choledochal cyst: a 10-year review.

Authors:  Kin Wai Edwin Chan; Kim Hung Lee; Siu Yan Bess Tsui; Jennifer Wai Cheung Mou; Yuk Him Peter Tam
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

5.  Laparoscopic management for prenatally diagnosed choledochal cysts.

Authors:  Mariko Matsumoto; Naoto Urushihara; Koji Fukumoto; Masaya Yamoto; Hiromu Miyake; Hideaki Nakajima
Journal:  Surg Today       Date:  2016-03-02       Impact factor: 2.549

6.  Different characteristics of infants diagnosed with congenital choledochal malformation prenatally or postnatally.

Authors:  Wei Chen; Jia Geng; Ya-Lan Tan; Lian Zhao; Hui-Hui Jia; Wan-Liang Guo
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

7.  Accuracy of Magnetic Resonance Imaging in Prenatal Diagnosis of Choledochal Cysts: A Single-Center Retrospective Analysis.

Authors:  Huiying Wu; Jinsheng Tian; Hehong Li; Hongsheng Liu; Yutao Liu; Lianwei Lu; Xiwen Chen; Xiaochun Zhang; Wenbiao Xu
Journal:  Int J Clin Pract       Date:  2022-09-26       Impact factor: 3.149

8.  Management of choledochal cyst: Evolution with antenatal diagnosis and laparoscopic approach.

Authors:  Abdelmounim Cherqaoui; Mirna Haddad; Celine Roman; Guillaume Gorincour; Jean Yves Marti; Arnaud Bonnard; Jean-Michel Guys; Pascal de Lagausie
Journal:  J Minim Access Surg       Date:  2012-10       Impact factor: 1.407

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.